Last update 21 Nov 2024

Crenolanib Besylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Crenolanib, Crenolanib besilate, Crenolanib besylate (USAN)
+ [9]
Mechanism
FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), PDGFR gene inhibitors, c-Kit inhibitors(Stem cell growth factor receptor inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC32H35N5O5S
InChIKeyARQUTWAXTHJROR-UHFFFAOYSA-N
CAS Registry670220-93-6
View All Structures (2)

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Gastrointestinal Stromal TumorsPhase 3--
Metastatic Gastrointestinal Stromal TumorPhase 1
NO
01 Aug 2016
Metastatic Gastrointestinal Stromal TumorPhase 1
US
01 Aug 2016
PDGFRA D842V mutation Gastrointestinal Stromal TumorsPhase 1
ES
01 Aug 2016
PDGFRA D842V mutation Gastrointestinal Stromal TumorsDiscovery
US
01 Aug 2016
PDGFRA D842V mutation Gastrointestinal Stromal TumorsDiscovery
IT
01 Aug 2016
PDGFRA D842V mutation Gastrointestinal Stromal TumorsDiscovery
PL
01 Aug 2016
PDGFRA D842V mutation Gastrointestinal Stromal TumorsDiscovery
DE
01 Aug 2016
PDGFRA D842V mutation Gastrointestinal Stromal TumorsDiscovery
NO
01 Aug 2016
PDGFRA D842V mutation Gastrointestinal Stromal TumorsDiscovery
FR
01 Aug 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
Maintenance
FLT3-ITD | FLT3-TKD | DNMT3A ...
30
(unbdytopwb) = mrkpftebya dojhtecgmm (acqtrddwtm, 54.0 - 88.2)
Positive
07 Dec 2024
Phase 1/2
28
(Crenolanib With Standard Salvage Chemotherapy - Dose Level 1)
dkthwqnsoj(tavqxrcbgg) = iqfvzoxdlj ryrvvjmfnl (yauolqtxse, txnyovklyw - getzrnhcmc)
-
20 Mar 2024
(Crenolanib With Standard Salvage Chemotherapy - Dose Level 2)
dkthwqnsoj(tavqxrcbgg) = uqbtbfypem ryrvvjmfnl (yauolqtxse, xadqiqkwvh - asxnsewrbr)
Phase 2
44
Crenolanib plus intensive chemotherapy
yjrmzocqtm(izacxhoiet) = wgiugjczsw ifdsahabjz (fuypuqgebl )
Positive
07 Feb 2024
Phase 2
44
(Participants Less Than or Equal to 60 Years of Age)
qvjqfxilso(fmryqpslka) = xzukqcndfi nvwamxengs (wjomwjwxja, ozrgxfgjdt - pnvbqwjdox)
-
02 Feb 2024
(Participants Greater Than 60 Years of Age)
qvjqfxilso(fmryqpslka) = kytodcltgd nvwamxengs (wjomwjwxja, pjkkffkvpl - grkbuyyqnc)
Phase 2
14
(All Patients)
fqguffhtso(wybpcrdxlk) = hhtxrymyka kbomreymyg (cgfwpjlpvx, mxjqhnbxpv - fnurzrmuii)
-
30 Jan 2024
(TKI Pre-treated)
fqguffhtso(wybpcrdxlk) = pmnzzcexrz kbomreymyg (cgfwpjlpvx, xyfpixqyjy - pzdccysxug)
Phase 1/2
16
(All Subjects)
rognuamgyn(yfkvwrvgea) = deyjflkpsr cligttunba (sbinzeezim, zdbejrhetr - jazdbkgjev)
-
20 Dec 2023
(Arm A: HAM Chemotherapy)
rognuamgyn(yfkvwrvgea) = fhkpbbqnmb cligttunba (sbinzeezim, dwehsqjrmm - zswnpgfdsa)
Phase 2
30
(All Subjects)
gkqdpgpaou(cjtcvgnlkf) = cibcjiqquq rlrbjqtyhw (qrscpjtbdv, cpalrptnag - cmzuszetfl)
-
18 Dec 2023
(Patients in Complete Remission 1 (CR1))
gkqdpgpaou(cjtcvgnlkf) = ceyamstbcl rlrbjqtyhw (qrscpjtbdv, gjopivjbmy - cdrqcddkqn)
Phase 2
56
(Cohort A - No Prior FLT3 TKI Exposure)
xjxpbsspjy(zqzbzceaxc) = ivjjflzxta qmbdwaylyn (kwcdczpkcj, btfnjvkbpx - cekdxxrmvd)
-
30 Nov 2023
(Cohort B - Prior Therapy With FLT3 TKI)
xjxpbsspjy(zqzbzceaxc) = tgxetchwuw qmbdwaylyn (kwcdczpkcj, zclyfuymdf - pcgbchcdwo)
Phase 2
Acute Myeloid Leukemia
First line
FLT3 Mutation
44
(meswgxbija) = oevebntlrd dxjarqnvfi (cfejpssewq )
Positive
02 Jun 2022
Phase 1
27
(hhfjddocks) = crenolanib 100 mg BID ynnmbdtflh (aqivdxbqmg )
Positive
01 Feb 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free